Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate

International Journal of Cancer. Journal International Du Cancer
M D NorrisI B Roninson

Abstract

Cellular resistance to methotrexate (MTX) is believed to be unaffected by expression of MDR1 P-glycoprotein (Pgp), a pleiotropic efflux pump acting on different hydrophobic compounds that enter cells by passive diffusion. A series of human leukemic CCRF-CEM sublines, isolated by multi-step selection for very high resistance to MTX, exhibit multiple mechanisms of MTX resistance, including decreased carrier-mediated uptake of MTX and DHFR gene amplification. These sublines show cross-resistance to drugs of the multi-drug resistance (MDR) family, which is correlated with relative resistance to MTX. The MTX-selected sublines show increased expression and function of the MDR1 gene, based on the measurement of MDR1 mRNA, Pgp and rhodamine 123 accumulation. Sequence analysis of the MDR1 cDNA from MTX-selected CCRF-CEM cells revealed no mutations in the protein coding region. MTX resistance in these cell lines is partially reversible by a Pgp-specific monoclonal antibody (MAb) UIC2 and a monovalent FaB fragment of UIC2. Our results indicate that Pgp can contribute to multifactorial resistance to MTX.

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E B Mechetner, I B Roninson
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K E NoonanI B Roninson
Jan 1, 1990·Annual Review of Nutrition·G B Henderson
Jan 1, 1984·Advances in Enzyme Regulation·W T Beck
Jan 15, 1982·Biochemical Pharmacology·B T HillJ H Goldie
Apr 21, 1993·Journal of the National Cancer Institute·P M Chaudhary, I B Roninson
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan

❮ Previous
Next ❯

Citations

Mar 14, 2013·BioMed Research International·Radosław JanuchowskiMaciej Zabel
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Feb 9, 2010·Pharmacogenomics·Wouter M KooloosHenk-Jan Guchelaar
Mar 25, 2015·Expert Opinion on Drug Metabolism & Toxicology·Anna Klukovits, Peter Krajcsi
Jun 3, 2010·BMC Cancer·Nuria MencíaCarlos J Ciudad
Mar 17, 2017·Inflammatory Bowel Diseases·Aze WilsonRichard B Kim
Sep 22, 2007·The Journal of Pharmacy and Pharmacology·Tomoharu YokoojiMikihisa Takano
Feb 4, 2006·Life Sciences·Marilyn E Morris, Shuzhong Zhang
Mar 1, 2017·Clinical and Experimental Medicine·Edsaul Emilio Perez-GuerreroLaura Gonzalez-Lopez
Oct 25, 2003·Oncogene·Rongbao Zhao, I David Goldman
Apr 29, 2006·Arthritis and Rheumatism·Prabha Ranganathan, Howard L McLeod
Aug 26, 2006·European Journal of Clinical Pharmacology·Marek DrozdzikMagdalena Herczynska
Jan 5, 2007·Nature Clinical Practice. Rheumatology·Joost W van der HeijdenGerrit Jansen
Feb 5, 2005·Arthritis and Rheumatism·Prabha Ranganathan, Howard L McLeod
Nov 6, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Véronique MargueriteMarc Merten
Jul 9, 2008·Biochemistry. Biokhimii︠a︡·A A Stavrovskaya, T P Stromskaya
Jul 16, 2010·Expert Review of Molecular Diagnostics·Zsolt B NagyJózsef Gábor Joó
Jul 6, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Agnès PoirierChristoph Funk
Jan 24, 2004·The Journal of Pharmacy and Pharmacology·Kouya YamakiShin Yoshino
Feb 9, 2005·International Journal of Immunopathology and Pharmacology·K YamakiS Yoshino
Aug 28, 2020·Journal of Ophthalmology·Ge Wang, Xiaoyan Peng
Jan 23, 2021·RSC Medicinal Chemistry·Vítor YangNuno Vale
Oct 1, 1996·Current Opinion in Genetics & Development·M M GottesmanS V Ambudkar
Jun 19, 2021·Journal of Pharmacokinetics and Pharmacodynamics·Mohammed A A SalehElizabeth C M De Lange
Jun 28, 2013·Journal of Chemical Information and Modeling·Ricardo J FerreiraDaniel J V A dos Santos
Jul 21, 2011·Molecular Pharmaceutics·Chung-Pu WuYu-Shan Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.